T. Xu

发表

Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma

J. Paulson, Yanwen Jiang, C. Bolen, 2022, BMC Cancer.

Venetoclax and Hypomethylating Agents as First-line Treatment in Newly Diagnosed Patients with AML in a Predominately Community Setting in the US

A. Gershon, M. Onishi, W. Donnellan, 2022, The oncologist.

Early Real-World First-Line Treatment With Venetoclax Plus HMAs Versus HMA Monotherapy Among Patients With AML in a Predominately US Community Setting.

A. Gershon, D. Greenwald, V. Kota, 2023, Clinical lymphoma, myeloma & leukemia.

Monitoring of postoperative neutrophil-to-lymphocyte ratio, D-dimer, and CA153 in: Diagnostic value for recurrent and metastatic breast cancer

M. Ren, Zhiyao Ren, Yunfeng Xu, 2023, Frontiers in Surgery.

Chinese experts’ consensus on the Internet of Things-aided diagnosis and treatment of coronavirus disease 2019 (COVID-19)

Jian Zhou, Tao Xu, Min Zhang, 2020, Clinical eHealth.

Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis

S. Karve, S. Ailawadhi, S. Atrash, 2022, Blood Cancer Journal.

RMHP_A_270326 1603..1611

Yongzeng Feng, Xiaoyu Dong, Guangheng Xiang, 2020 .

The association between frailty of older stroke patients during hospitalization and one-year all-cause mortality: A multicenter survey in China

J. Jiao, Xinjuan Wu, Tao Xu, 2022, International journal of nursing sciences.

Efficacy and safety of cycloserine-containing regimens in the treatment of multidrug-resistant tuberculosis: a nationwide retrospective cohort study in China

H. Pan, Y. Pang, Lixia Wang, 2019, Infection and drug resistance.

Nutritional Status According to the Short-Form Mini Nutritional Assessment (MNA-SF) and Clinical Characteristics as Predictors of Length of Stay, Mortality, and Readmissions Among Older Inpatients in China: A National Study

D. Lv, Jingfen Jin, Ming-lei Zhu, 2022, Frontiers in Nutrition.

RWD-derived response in multiple myeloma

K. Yousefi, S. Tyanova, Shaji K. Kumar, 2023, PloS one.

Clinical Characteristics and Treatment Outcomes of Testicular Myeloid Sarcomas After Hematopoietic Stem Cell Transplantation: A Single-institution Experience.

Yiqing Du, Qing Li, T. Xu, 2021, Clinical genitourinary cancer.

A Retrospective Study of Oral Emergency Services During COVID-19

Tao Xu, Hua-Qiu Guo, A. Ji, 2021, International Dental Journal.

Long‐term outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab in a real‐world setting

R. Ofori-Asenso, A. Röth, A. Shang, 2023, European journal of haematology.

Clinical Profile and Long-Term Outcomes of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in a Real-World Setting: High Frequency of Anemia Despite Decreased Intravascular Hemolysis

R. Ofori-Asenso, A. Shang, F. Alashkar, 2021, Blood.

Trial in Progress: A Real-World Cohort Study Reporting Patient Profiles, Clinical Outcomes, and Unmet Medical Need of Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Eculizumab in the Essen Center in Germany

I. Faghmous, A. Röth, A. Shang, 2020 .

Use of Venetoclax (VEN) and Hypomethylating Agents (HMA) in Newly Diagnosed Acute Myeloid Leukemia (AML) in the United States (US) - Real World (RW) Response, Treatment Duration, Dose and Schedule Modifications

G. Ramsingh, W. Donnellan, Huan Jin, 2020 .

Channeling effects in the prescription of new therapies: the case of emicizumab for hemophilia A.

P. Kuebler, A. Mahajerin, F. Nissen, 2022, Journal of comparative effectiveness research.